Patents by Inventor David W. Barry
David W. Barry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11943876Abstract: Pre-connected analyte sensors are provided. A pre-connected analyte sensor includes a sensor carrier attached to an analyte sensor. The sensor carrier includes a substrate configured for mechanical coupling of the sensor to testing, calibration, or wearable equipment. The sensor carrier also includes conductive contacts for electrically coupling sensor electrodes to the testing, calibration, or wearable equipment.Type: GrantFiled: October 23, 2018Date of Patent: March 26, 2024Assignee: DexCom, Inc.Inventors: Jason Halac, John Charles Barry, Becky L. Clark, Chris W. Dring, John Michael Gray, Kris Elliot Higley, Jeff Jackson, David A. Keller, Ted Tang Lee, Jason Mitchell, Kenneth Pirondini, David Rego, Ryan Everett Schoonmaker, Peter C. Simpson, Craig Thomas Gadd, Kyle Thomas Stewart, John Stanley Hayes
-
Patent number: 10055307Abstract: The present disclosure is related to methods, systems, and machine-readable media for workflows for series of snapshots. A server can manage replication of a number of series of snapshots of a virtual computing instance (VCI). An on-host agent can replicate a parent series of the number of series of snapshots to at least one child series of the number of series of snapshots. The parent series can precede the at least one child series in the number of series of snapshots. A change in the parent series can be propagated to the child series. Management of the replication of the numbers of series of snapshots can be switched from the server to a different server.Type: GrantFiled: June 30, 2015Date of Patent: August 21, 2018Assignee: VMware, Inc.Inventors: Joanne Ren, David W. Barry, Keith Farkas, Mike Zucca, Martin Valkanov
-
Patent number: 9891938Abstract: The present disclosure is related to methods, systems, and machine-readable media for modifying an instance catalog to perform operation. A storage system can include a plurality of packfiles that store data. The storage system can include a plurality of streams that include a plurality of hashes that identify the plurality of packfiles. The storage system can include an instance catalog that includes an identification of the plurality of streams. The storage system can include an operation engine to perform a number of operations on the plurality of packfiles by modifying the instance catalog using the identification of the plurality of streams.Type: GrantFiled: June 26, 2015Date of Patent: February 13, 2018Assignee: VMware, Inc.Inventors: David W. Barry, Joanne Ren, Mike Zucca, Keith Farkas
-
Publication number: 20170004051Abstract: The present disclosure is related to methods, systems, and machine-readable media for workflows for series of snapshots. A server can manage replication of a number of series of snapshots of a virtual computing instance (VCI). An on-host agent can replicate a parent series of the number of series of snapshots to at least one child series of the number of series of snapshots. The parent series can precede the at least one child series in the number of series of snapshots. A change in the parent series can be propagated to the child series. Management of the replication of the numbers of series of snapshots can be switched from the server to a different server.Type: ApplicationFiled: June 30, 2015Publication date: January 5, 2017Applicant: VMWARE, INC.Inventors: Joanne Ren, David W. Barry, Keith Farkas, Mike Zucca, Martin Valkanov
-
Publication number: 20160378516Abstract: The present disclosure is related to methods, systems, and machine-readable media for modifying an instance catalog to perform operation. A storage system can include a plurality of packfiles that store data. The storage system can include a plurality of streams that include a plurality of hashes that identify the plurality of packfiles. The storage system can include an instance catalog that includes an identification of the plurality of streams. The storage system can include an operation engine to perform a number of operations on the plurality of packfiles by modifying the instance catalog using the identification of the plurality of streams.Type: ApplicationFiled: June 26, 2015Publication date: December 29, 2016Applicant: VMWARE, INC.Inventors: David W. Barry, Joanne Ren, Mike Zucca, Keith Farkas
-
Publication number: 20090247487Abstract: The present invention is directed to a method for treating hepatitis B virus infection in humans comprising administering a synergistically effective amount of agents having known anti-hepatitis B virus activity in combination or alternation. Specifically, the invention is directed to a method for treating hepatitis B virus infection comprising administering FTC in combination or alternation with penciclovir, famciclovir or Bis-POM-PMEA. Additionally, the invention is directed to a method for treating hepatitis B virus infection comprising administering L-FMAU in combination or alternation with DAPD, penciclovir or Bis-POM-PMEA. The invention is further directed to a method for treating hepatitis B virus infection comprising administering DAPD in combination or alternation with Bis-POM-PMEA.Type: ApplicationFiled: June 12, 2009Publication date: October 1, 2009Applicant: GILEAD SCIENCES, INC.Inventors: Phillip A. Furman, George R. Painter, III, David W. Barry, Franck Rousseau
-
Patent number: 7572800Abstract: The present invention is directed to a method for treating hepatitis B virus infection in humans comprising administering a synergistically effective amount of agents having known anti-hepatitis B virus activity in combination or alternation. Specifically, the invention is directed to a method for treating hepatitis B virus infection comprising administering FTC in combination or alternation with penciclovir, famciclovir or Bis-POM-PMEA. Additionally, the invention is directed to a method for treating hepatitis B virus infection comprising administering L-FMAU in combination or alternation with DAPD, penciclovir or Bis-POM-PMEA. The invention is further directed to a method for treating hepatitis B virus infection comprising administering DAPD in combination or alternation with Bis-POM-PMEA.Type: GrantFiled: February 25, 2003Date of Patent: August 11, 2009Assignee: Gilead Sciences, Inc.Inventors: Phillip A. Furman, George R. Painter, III, David W. Barry, Franck Rousseau
-
Publication number: 20030158150Abstract: The present invention is directed to a method for treating hepatitis B virus infection in humans comprising administering a synergistically effective amount of agents having known anti-hepatitis B virus activity in combination or alternation. Specifically, the invention is directed to a method for treating hepatitis B virus infection comprising administering FTC in combination or alternation with penciclovir, famciclovir or Bis-POM-PMEA. Additionally, the invention is directed to a method for treating hepatitis B virus infection comprising administering L-FMAU in combination or alternation with DAPD, penciclovir or Bis-POM-PMEA. The invention is further directed to a method for treating hepatitis B virus infection comprising administering DAPD in combination or alternation with Bis-POM-PMEA.Type: ApplicationFiled: February 25, 2003Publication date: August 21, 2003Applicant: Triangle Pharmaceuticals, Inc.Inventors: Phillip A. Furman, George R. Painter, David W. Barry, Franck Rousseau
-
Patent number: 6528515Abstract: The present invention is directed to a method for treating hepatitis B virus infection in humans comprising administering a synergistically effective amount of agents having known anti-hepatitis B virus activity in combination or alternation. Specifically, the invention is directed to a method for treating hepatitis B virus infection comprising administering FTC in combination or alternation with penciclovir, famciclovir or Bis-POM-PMEA. Additionally, the invention is directed to a method for treating hepatitis B virus infection comprising administering L-FMAU in combination or alternation with DAPD, penciclovir or Bis-POM-PMEA. The invention is further directed to a method for treating hepatitis B virus infection comprising administering DAPD in combination or alternation with Bis-POM-PMEA.Type: GrantFiled: November 2, 1999Date of Patent: March 4, 2003Assignee: Triangle Pharmaceuticals, Inc.Inventors: Phillip A. Furman, George R. Painter, III, David W. Barry, Franck Rousseau
-
Patent number: 6410546Abstract: Use of MKC-442 in combination with other antiviral agents for the treatment of patients infected with HIV is disclosed.Type: GrantFiled: April 7, 1998Date of Patent: June 25, 2002Assignee: Triangle Pharmaceuticals, Inc.Inventors: Phillip A. Furman, Cary P. Moxham, David W. Barry, Katyna Borroto-Esoda
-
Publication number: 20020002166Abstract: Use of MKC-442 in combination with other antiviral agents for the treatment of patients infected with HIV is disclosed.Type: ApplicationFiled: August 14, 2001Publication date: January 3, 2002Inventors: Phillip A. Furman, Cary P. Moxham, David W. Barry, Katyna Borroto-Esoda
-
Patent number: 6188988Abstract: Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen for a known disease such as HIV infection are disclosed. The method comprises (a) providing patient information to a computing device (the computer device comprising: a first knowledge base comprising a plurality of different therapeutic treatment regimens for the disease; a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for the disease; and a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of the different therapeutic treatment regimens; and (b) generating in the computing device a listing (preferably a ranked listing) of therapeutic treatment regimens for the patient; and (c) generating in the computing device advisory information for one or more treatment regimens in the listing based on the patient information and the expert rules.Type: GrantFiled: March 10, 2000Date of Patent: February 13, 2001Assignee: Triangle Pharmaceuticals, Inc.Inventors: David W. Barry, Carolyn S. Underwood, Bruce J. McCreedy, David D. Hadden, Jason L. Lucas
-
Patent number: 6081786Abstract: Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen for a known disease such as HIV infection are disclosed. The method comprises (a) providing patient information to a computing device (the computer device comprising: a first knowledge base comprising a plurality of different therapeutic treatment regimens for the disease; a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for the disease; and a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of the different therapeutic treatment regimens; and (b) generating in the computing device a listing (preferably a ranked listing) of therapeutic treatment regimens for the patient; and (c) generating in the computing device advisory information for one or more treatment regimens in the listing based on the patient information and the expert rules.Type: GrantFiled: April 1, 1999Date of Patent: June 27, 2000Assignee: Triangle Pharmaceuticals, Inc.Inventors: David W. Barry, Carolyn S. Underwood, Bruce J. McCreedy, David D. Hadden, Jason L. Lucas
-
Patent number: 5145840Abstract: A method of treating idiopathic thrombocytopaenia purpura with 2',3'-dideoxy-3'-azidonucleosides, in particular 3'-azido-3'-deoxythymidine, is disclosed.Type: GrantFiled: April 2, 1991Date of Patent: September 8, 1992Assignee: Burroughs Wellcome Co.Inventors: Leone E. Kirk, III, Dannie H. King, Richard H. Clemons, Sandra N. Lehrman, David W. Barry
-
Patent number: 5093114Abstract: Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof.Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.Type: GrantFiled: November 30, 1990Date of Patent: March 3, 1992Assignee: Burroughs Wellcome Co.Inventors: Janet L. Rideout, David W. Barry, Sandra N. Lehrmaan, Martha H. St. Clair, Phillip A. Furman
-
Patent number: 5086044Abstract: Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof. Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose. Additionally, there is disclosed the treatment of Kaposi's sarcoma with 3'-azido-3'-deoxythymidine (AZT) and the synergistic activity in the treatment of humans infected with HTLV-III of AZT and interferon as well as AZT and acyclovir.Type: GrantFiled: April 18, 1990Date of Patent: February 4, 1992Assignee: Burroughs Wellcome Co.Inventors: Janet L. Rideout, David W. Barry, Sandra N. Lehrman, Martha H. St. Clair, Phillip A. Furman
-
Patent number: 4874609Abstract: Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof.Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.Type: GrantFiled: February 8, 1988Date of Patent: October 17, 1989Assignee: Burroughs Wellcome Co.Inventors: Janet L. Rideout, David W. Barry, Sandra N. Lehrman, Martha H. St. Clair, Phillip A. Furman
-
Patent number: 4857511Abstract: Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof.Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.Type: GrantFiled: February 8, 1988Date of Patent: August 15, 1989Assignee: Burroughs Wellcome Co.Inventors: Janet L. Rideout, David W. Barry, Sandra N. Lehrman, Martha H. St. Clair, Phillip A. Furman
-
Patent number: 4847244Abstract: Treatments of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof.Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.Type: GrantFiled: October 20, 1987Date of Patent: July 11, 1989Assignee: Burroughs Wellcome Co.Inventors: Janet L. Rideout, David W. Barry, Sandra N. Lehrman, Martha H. St. Clair, Phillip A. Furman
-
Patent number: 4837208Abstract: Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof.Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.Type: GrantFiled: October 20, 1987Date of Patent: June 6, 1989Assignee: Burroughs Wellcome Co.Inventors: Janet L. Rideout, David W. Barry, Sandra N. Lehrman, Martha H. St. Clair, Phillip A. Furman